ADDRESSING AUSTRALIA’S BOWEL CANCER SCREENING PARTICIPATION GAP New educational videos aim to strengthen frontline engagement and improve the return of screening kits
With
Associate Professor Tarik Sammour,
Colorectal Surgeon, Royal Adelaide Hospital &
|Associate Professor of Surgery, Adelaide University
SEGMENT
Filmed in Adelaide | November 2026
Improving participation in Australia’s National Bowel Cancer Screening Program (NBCSP) remains an important public health priority, with many eligible Australians failing to return their screening kits.
In an interview with Australian Health Journal, Associate Professor Tarik Sammour, Colorectal Surgeon at the Royal Adelaide Hospital and Associate Professor of Surgery at Adelaide University, highlighted the need to make screening easier to understand and encourage greater participation.
The Australian Institute of Health and Welfare’s (AIHW) National Bowel Cancer Screening Program Monitoring Report 2026 found that just 42% of the 6.4 million Australians invited to screen between January 2023 and December 2024 participated. Sammour noted that participation can fall to around 30% among populations where English is not the first language.
Two common barriers are putting off completing the test and feeling uncomfortable about providing a stool sample. However, he emphasised that the process is simpler than many people expect.
“The first message is that bowel cancer screening saves lives. This is a simple test that could potentially save your life,” he said.
The AIHW report highlights the program’s impact, with 17,378 bowel cancers detected since its introduction in 2006. Mortality among Australians aged 50–74 has also fallen from 44 deaths per 100,000 people in 2006 to an estimated 23 in 2025.
Sammour advocated greater involvement from GPs, specialists and community leaders, supported by educational videos developed for frontline health workers and community groups.
“Bowel cancer screening needs to be championed and discussed at every level,” he said, encouraging eligible Australians to complete their kits and remind others to do the same.
Videos hosted on the Cancer Council Australia’s YouTube Channel https://www.youtube.com/@cancercouncilaustralia
Source: Adapted from transcript and AIHW media release (June 2026)
You Might also like
-
Enhancing occupational therapy service provision with military veterans
Almost half a million Australians have served with the Australian Defence Force. Given the high prevalence of physical and mental health conditions and complexity of civilian life adjustment after military service, high-quality occupational therapy services are critical. However, there is limited description of occupational therapy service provision to individuals funded by the Australian Department of Veterans’ Affairs to inform government policy.
A cross-sectional study, led by Professor Carol McKinstry, Professor of Occupational Therapy and Deputy Dean with La Trobe University’s Rural Health School at the Bendigo campus has used an online survey to collect information from occupational therapists providing services to Department of Veterans’ Affairs clients.
-
Global MedTech company brings device reprocessing plant to Australia
Cardinal Health is global medical products manufacturer and leading provider of single-use device reprocessing services in the U.S. In Australia and New Zealand, as one of the largest suppliers of medical devices, announced on 23 May 2024 that it will be opening a single-use medical device reprocessing facility in Australia – its first reprocessing facility outside the United States.
On 18 March 2025 at the Health Innovation Living Lab at the John Hunter Hospital, a further announcement was made, on the chosen single-use medical device remanufacturing facility in Beresfield, Newcastle, set to commence operation late 2025, supported by the NSW Department of Primary Industries and Regional Development.
-
Ensuring stringent quality standards in the lifecycle of medical devices
Dr Jasjit Baveja is the Associate Director of Policy at the Medical Technology Association of Australia (MTAA), where she oversees regulatory affairs, clinical code of practice, procurement, industry policy, reimbursement, and advocacy. With over 20 years of experience in the medical device regulatory space, Dr Bavej’s expertise lies in providing educational opportunities for regulatory professionals in Australia to ensure continuous learning and professional development. She collaborates closely with the Therapeutic Goods Administration (TGA) to run workshops that provide invaluable experience, networking opportunities, and skill enhancement.